Diabetic neuropathy, a debilitating complication of diabetes, affects millions of patients, causing chronic nerve pain and significantly diminishing their quality of life. Dr. Michael Fishman, a leader in pain management, champions Spinal Cord Stimulation (SCS) as a proven and effective treatment for patients suffering from diabetic peripheral neuropathy (DPN).

At his practice on-site at Lebanon Internal Medicine Associates, Dr. Fishman utilizes advanced technology now offering patients Inceptiv SCS, an innovative FDA-approved approach to pain relief that is both non-invasive and long-lasting.

Understanding diabetic neuropathy symptoms

Diabetic peripheral neuropathy occurs when prolonged high blood sugar levels damage the nerves, most commonly in the feet and legs. Patients often experience a range of symptoms, including:

Numbness or tingling in the extremities
Burning or sharp pain
Heightened sensitivity to touch
Muscle weakness
Difficulty with balance or coordination

As DPN progresses, these symptoms can become severe, leading to ulcers, infections, or even the risk of amputation.

Dr. Fishman champions spinal cord stimulation for relief

Dr. Michael Fishman strongly supports Spinal Cord Stimulation (SCS), a minimally invasive procedure that uses electrical impulses to block pain signals from reaching the brain. In his practice, Dr. Fishman uses Inceptiv’s advanced SCS technology, which includes diabetic foot pain associated with DPN as one condition for which SCS might be an option.

An FDA-approved treatment for lasting pain relief

Inceptiv SCS therapy is an FDA-approved treatment option for DPN pain that disrupts pain signals, providing an effective alternative for patients who have struggled with other treatment methods. The implantable device may be an ideal fit for individuals who:

Experience pain in the legs or feet
Have had DPN pain for at least a year
Have not had success managing DPN pain with their current treatment
Have DPN pain that negatively impacts sleep and quality of life

By contrast to the traditional suboptimal therapy experiences, Inceptiv SCS senses biological signals and consistently maintains the physician’s prescribed stimulation that is tailored to a patient’s needs. Inceptiv also offers unparalleled access to diagnostic imaging, with 1.5T and 3T full-body MRI access with no power or impedance restrictions.

SCS therapy has been shown to reduce pain by 50% or more in over 60% of patients suffering from painful diabetic neuropathy, according to clinical studies published in Diabetes Care. Dr. Fishman emphasizes that SCS not only reduces pain but also improves patients’ mobility, sleep, and overall quality of life.

For more information about Dr. Fishman’s approach to diabetic neuropathy treatment, view this informative video: Watch Here.

A new era of pain management

Dr. Fishman’s practice is at the forefront of pain management, offering patients a comprehensive approach to treating diabetic neuropathy. As a champion of Spinal Cord Stimulation, he provides consultations and administers this life-changing Inceptiv therapy to those in need. His goal is to empower patients with advanced treatments that help them reclaim their lives from chronic pain.

For more information or to schedule a consultation with Dr. Michael Fishman regarding SCS therapy, please contact 717-273-6706 x1145 or visit doctorfishman.com.

About Dr. Michael Fishman

Dr. Michael Fishman is a double board-certified Anesthesiologist and Interventional Pain Specialist with extensive experience treating patients with a variety of painful conditions. He has designed and participated in over thirty clinical trials in the field of pain medicine and neurostimulation. He has authored more than 80 peer-reviewed abstracts, book chapters and publications in the scientific literature and has presented his work at numerous local, regional, and international society meetings. The wide-ranging nature of pain care and pain treatments is reflected in the diversity of research performed in his clinic. Dr. Michael Fishman received a BA from Franklin & Marshall College and received his MD from Jefferson Medical College.